[1]Almad AA, Doreswamy A, Gross SK, et al. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis[J]. Glia, 2016, 64(7): 1154-1169.
[2]Capani F, Quarracino C, Caccuri R, et al. Astrocytes as the main players in primary degenerative disorders of the human central nervous system[J]. Front Aging Neurosci, 2016, 8: 45.
[3]Cekanaviciute E, Buckwalter MS. Astrocytes: integrative regulators of neuroinflammation in stroke and other neurological diseases[J]. Neurotherapeutics, 2016, 13(4): 685-701.
[4]Dooves S, Bugiani M, Postma NL, et al. Astrocytes are central in the pathomechanisms of vanishing white matter[J]. J Clin Invest, 2016, 126(4): 1512-1524.
[5]周新茹, 金倩, 张蕾蕾, 等. 人脐带间充质干细胞来源外泌体促进小胶质细胞向M2极化[J]. 江苏大学学报(医学版), 2020, 30(4): 277-281.
[6]Contreras JE, Sáez JC, Bukauskas FF, et al. Gating and regulation of connexin 43 (Cx43) hemichannels[J]. Proc Natl Acad Sci U S A, 2003, 100(20): 11388-11393.
[7]Davidson JO, Drury PP, Green CR, et al. Connexin hemichannel blockade is neuroprotective after asphyxia in preterm fetal sheep[J]. PLoS One, 2014, 9(5): e96558.
[8]Davidson JO, Green CR, Nicholson LF, et al. Deleterious effects of high dose connexin 43 mimetic peptide infusion after cerebral ischaemia in nearterm fetal sheep[J]. Int J Mol Sci, 2012, 13(5): 6303-6319.
[9]FreitasAndrade M, Naus CC. Astrocytes in neuroprotection and neurodegeneration: the role of connexin43 and pannexin1[J]. Neuroscience, 2016, 323: 207-221.
[10]Schulz R, Grge PM, Grbe A, et al. Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection[J]. Pharmacol Ther, 2015, 153: 90-106.
[11]Ambrosi C, Ren C, Spagnol G, et al. Connexin43 forms supramolecular complexes through nonoverlapping binding sites for drebrin, tubulin, and ZO1[J]. PLoS One, 2016, 11(6): e0157073.
[12]Francis R, Xu X, Park H, et al. Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics[J]. PLoS One, 2011, 6(10): e26379.
[13]Leithe E, Mesnil M, Aasen T, The connexin 43 Cterminus: a tail of many tales[J]. Biochim Biophys Acta Biomembr, 2018, 1860(1): 48-64.
[14]Imoto S, Sawamura T, Shibuya Y, et al. Labile iron, ROS, and cell death are prominently induced by haemin, but not by nontransferrinbound iron[J]. Transfus Apher Sci, 2021, 103319.
[15]Sun T, Chi JT. Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: the therapeutic implications[J]. Genes Dis, 2021, 8(3): 241-249.
[16]Bélanger M, Magistretti PJ. The role of astroglia in neuroprotection[J]. Dialogues Clin Neurosci, 2009, 11(3): 281-295.
[17]Kielian T. Glial connexins and gap junctions in CNS inflammation and disease[J]. J Neurochem, 2008, 106(3): 1000-1016.
[18]Li T, Giaume C, Xiao L. Connexinsmediated glia networking impacts myelination and remyelination in the central nervous system[J]. Mol Neurobiol, 2014, 49(3): 1460-1471.
[19]Macco R, Pelizzoni I, Consonni A, et al. Astrocytes acquire resistance to irondependent oxidative stress upon proinflammatory activation[J]. J Neuroinflammation, 2013, 10: 130.
[20]Yang Y, Ren J, Sun Y, et al. A connexin43/YAP axis regulates astroglialmesenchymal transition in hemoglobin induced astrocyte activation[J]. Cell Death Differ, 2018, 25(10): 1870-1884.
[21]刘晓梅, 赵聃, 庞蓉蓉, 等. 小鼠脑内星形胶质细胞体外培养方法的优化[J]. 江苏大学学报(医学版), 2012, 22(6): 465-467, 471.
[22]Yu M, Lin Z, Tian X, et al. Downregulation of Cx43 reduces cisplatininduced acute renal injury by inhibiting ferroptosis[J]. Food Chem Toxicol, 2021, 158: 112672.
[23]Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer[J]. Cell, 2015, 163(4): 811-828.
[24]Qin Y, Pei Z, Feng Z, et al. Oncogenic activation of YAP signaling sensitizes ferroptosis of hepatocellular carcinoma via ALOXE3mediated lipid peroxidation accumulation[J]. Front Cell Dev Biol, 2021, 9: 751593.
[25]Wu J, Minikes AM, Gao M, et al. Intercellular interaction dictates cancer cell ferroptosis via NF2YAP signalling[J]. Nature, 2019, 572(7769): 402-406.
[26]Yang WH, Ding CC, Sun T, et al. The hippo pathway effector TAZ regulates ferroptosis in renal cell carcinoma[J]. Cell Rep, 2019, 28(10): 2501-2508.
|